chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Three hours post vaccines, T to 104 degrees. Mom noticed 3-30 sec. jerking of four extremities within one hour. Taken to hosp. then transferred and admitted to another hospital. LP bloody-no cell count; WBC 11.8; UA NL. Received ceftriaxons, acyclovir x 48 hrs. Cultures CSF; Bl neg at 48 hrs and pt discharged home. Incidently infant began vomiting on 2nd hosp day; discharged when c/s neg-vomiting continued-readmit < 24 hrs w/ dx pyloric stenosis.
I got a severe headache, was seeing double, everything tasted like metal, couldn't stop throwing up, elevated blood pressure.  I went to the ER on 2-28-21 and they gave me pain medicine, medicine to stop throwing up, and fluids through IV.  On 3-5-21 I went to my primary care doctor because I still felt dizzy.  Blood pressure 166 so she gave me blood pressure medicine.
5 minutes after vaccination, Attendee tried to stand up and fell forward - nurse caught her and assisted Attendee to floor. Vitals ok - EMS were called. Mother was in attendance and was anxious and a bit tachypneic. EMS arrived after 2 minutes - Glucose was 74, took Attendee to local hospital.
Within an hour but after the 30 minute waiting period the patient began to experience lightheadedness, flushing, and nausea. Recieved 50 mg of IM benadryl(works in medical facility). Patient improved and was discharged to family.
Case previously recorded as MA2009-4072. Initial case report received from a physician, via Novartis Medical Communication on 09 NOV 2009. A 3-year-old female patient was vaccinated with 0.5 ml of S-OIV FLUVIRIN (batch no. 1008143P) i.m. on 06 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-007849.
This case was reported by a healthcare professional and described the occurrence of injection site cellulitis in a 5-year-old female subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix, GlaxoSmithKline) for prophylaxis. The subject had no pre-existing medical conditions. There were no concurrent medications. On 14 August 2006 the subject received 5th dose of Infanrix, intramuscularly, in the left thigh (lot AC14B033AA). On14 August 2006, the subject also received measles, mumps and rubella vaccine, strain not specified (MMR II, Merck) at an unspecified site of injection. On 15 August 206, 1 day after vaccination with Infanrix, the subject experienced injection site cellulitis, injection site redness, injection site warmth and swelling injection site. The subject was seen at a physician's office. The healthcare professional considered the events were clinically significant (or requiring intervention). At the time of initial reporting, 17 August 2006, the events were ongoing. The healthcare professional considered the events were probably related to vaccination with Infanrix. Follow-up information received on 05 September 2006 indicated that the events completely resolved and were related to treatment with Infanrix.
Patient is a 81 y.o. female with a history of HTN and HLD who presented to hospital 10/4/2023 with chest pain and tachycardia concerning for atrial fibrillation. Found to have COVID requiring low flow O2.    1. Chest pain: Suspect MSK given tenderness on exam. Troponin 26, 22. EKG on admit without ST changes. Suspected demand from tachycardia and AKI. Echo EF 60%. Pleurtic chest pain. No further workup necessary.  2. Elevated troponin: Suspect demand ischemia in setting of tachycardia, COVID, acute respiratory failure. In setting of AKI. EKG without ST changes.    3. COVID-19: Symptom onset 9/28/2023 with COVID+ swab 10/4/23. Did require O2 on admit. Initiated Decadron. Continue pulmonary hygiene. Assess LFTs for Remdesevir candidacy. Wean O2. Stopped decadron as off O2.  4. Acute Hypoxic Respiratory Failure: Presented with tachypnea and desaturations in ED. Not on home O2. Improved with 2L NC. May be related to above. Wean O2 as able. Added albuterol for wheezing. Resolved.  5. Severe sepsis: Suspect related to above. Presented with HR 115, RR 20 and AKI. S/p IVF with improvement. Has improved off abx, will continue to hold and monitor closely. BC negative, procalcitonin WNL.  6. Tachycardia: Suspect from above. Initially thought afib RVR. EP evaluated, no afib concerns at this time. S/p heparin gtt. Monitor on telemetry.  7. AKI: Baseline Cr 0.9?1. Cr on admission 1.49. Likely prerenal given history. S/p IVF with improvement. Resolved.  8. HTN: Per history. Home medications resumed with hold parameters. Monitor and titrate as indicated.
Elevated troponin Essential Hypertension Abmulatory dysfunction Generalized weakness COVID-19 infection Hypomagnesemia
pt adm to hosp on the eve of receiving 1st DTP/OPV sereis; t104; impression was probable reaction to pertussis; CBC & U/A unremarkable; pt was irritable also; lytes & gram stain of spinal fluid neg; CSF was clear; hospitalized 2 days; BC ne
Pneumonia; Pneumonia; This is a spontaneous report from a contactable consumer (patient's husband). A 78-year-old female patient received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (manufacturer unspecified), via an unspecified route of administration on 25Feb2021 (Batch/Lot number was not reported) as single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient got pneumonia on an unspecified date; the patient received Pneumonia vaccine a couple of years ago. It was not known the exact time the pneumonia started. It developed over a period of several day started with a mild fever and after the 2nd or 3rd day her fever spiked and that's when she was admitted to the hospital. No treatment done over the weekend, while she was in the nursing home. No treatment before going to the hospital other than calling the doctor and the doctor saying take her to the hospital. The adverse event also resulted in Emergency Room visit. The patient was hospitalized from 18Mar2021 to 26Mar2021. She had a lot of blood work done, a CT scan, an X-ray, the physicians have the result. The outcome of events was recovered on 24Mar2021 (as reported).  Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.  Information about lot/batch number has been requested.
About 1/2 hour after vaccine administration, my left deltoid swelled (mildly), and my left hand, arm, and shoulder started tingling.  I never lost feeling completely, but it took about 2 days total for the tingling to completely go away.
Swelling all confined to the extremity to which the immunization was given. Roughly a little bigger than quarter size.
Pt developed redness, swelling, pain to left thigh.  Dx: cellulitis to area - 9 cm erythematous indurated wheal on L medial inner upper thigh.  Prescribed Keflex.
A non-serious spontaneous report of non-productive cough has been received from a consumer concerning her son, subsequent to FLUMIST. Neither relevant past medical history nor concomitant medications had been reported for this patient. On 06-Oct-2011, the patient received FLUMIST. After receiving FLUMIST, the patient had non-productive cough for four days. The outcome of the event non-productive cough was recovered.
Initial unsolicited report received from a physician on 18 September 2015. This case involves a 43 year old (gender unknown) patient who was vaccinated with a [dose not reported] [route and dose series not reported] dose of RABIES VACCINE (batch number, expiry date site of administration were not reported) on 29 June 2015, received a dose of rabies vaccine (batch number, expiry date site of administration were not reported) on 22 June 2015 and received a dose of rabies vaccine (batch number, expiry date site of administration were not reported) on 15 June 2015. Medical history and concomitant medications were not reported. On an unspecified date, following the vaccination patient had dog bite. Patient laboratory investigation and corrective treatment was not reported. The outcome of event was unknown. Follow-up information received from a nurse on 02 November 2015. It was reported that the patient denies any adverse event after the rabies vaccine and the vaccine was not administred at office but done at urgent care unit. On an unknown date, the patient was recovered. List of documents held by sender: none.
This spontaneous report was received from a certified medical assistant and refers to six unspecified patients of unknown age and gender. The patients' concomitant medications, concurrent conditions, pertinent medical histories, drug reactions or allergies were not provided. On 12-JUL-2017 and 13-JUL-2017, the patients were administered 3 different doses of M-M-R II (lot # reported as M042846, expiration date 21-OCT-2018) and VARIVAX (lot # reported as N014366, expiration date 09-MAY-2019) (doses and route of administration were not reported). The administered doses of vaccines were reconstituted with sterile diluent (lot # N003192, expiration date 05-JUL-2019). Administered doses of vaccines experienced a temperature excursion from 47 degrees Fahrenheit to 77 degrees Fahrenheit on 09-JUL-2017, which lasted for a time frame of 12 hours, 10 minutes. There were no previous temperature excursions reported. A digital data logger was involved in recording the excursions. No adverse effects were reported. No further information was provided. Additional information has been requested.
chills, fatigue, brain fog. severe. body aches and pains. starting 09/29 till now. slight improvement 6 days later
nauseous, headache, arm pain and swelling, body aches, chills, sweats, fever
Sore arm/arm was really hurting; Swollen arm; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm/arm was really hurting), PERIPHERAL SWELLING (Swollen arm) and FATIGUE (Fatigue) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm/arm was really hurting), PERIPHERAL SWELLING (Swollen arm) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm/arm was really hurting), PERIPHERAL SWELLING (Swollen arm) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.
Pt was Fussy for 3 days with decreased PO intake.  Pt was inconsolable.  Pt was evaluated after 2 days and had normal exam except for inconsolable.  Mild swelling on right thigh where comvax and prevnar were given.  By day 4 pt was back to baseline.  No fevers during episode.
That evening around 9pm,  I started to feel achy, muscle aches, chills, shivering, fatigue and  low grade fever,  I woke up the next morning with the same flu like symptoms.  These symptoms resolved after 2 days but still feeling fatigue.  On 9/14/2021,  the injection site was red, hot and purple hue and growing larger.  My left arm all the way down to my fingers was swollen.  My left hand- pinky, ring and middle finger lost sensations and they felt numb and tingling and this lasted over 2 days and slowly the symptoms did  improved.   On 9/15/2021 I also had tingling in my left foot, tingling toes and my ankles were swollen.   I also had a swollen lymph node on the left side of my arm pit.  It was large enough that it was protruding into my chest.  It was bigger than my fist.   I did consult with my doctor and they recommended to take Benadryl and ibuprofen.  Currently, I am still having brain fog,  stiffness and soreness around my neck/shoulder,  and decreased mobility of my left arm,
Ant bite looking rash. In clusters on my forearm, hips, butt and a few on hands. Doesn?t itch but it is tender. It is not shingles.
Swelling of left Knee, left hip, left arm and kidney; Swelling of left Knee, left hip, left arm and kidney; Swelling of left Knee, left hip, left arm and kidney; Swelling of left Knee, left hip, left arm and kidney; Labored breathing; Exhaustion; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 30Apr2021 at 12:00 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021 at 15:00, the patient experienced labored breathing and exhaustion and felt that, it was targeting every vulnerable part of her body, swelling of left (L) Knee, left (L) hip, left (L) arm and kidney. The events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of adverse events labored breathing and exhaustion and felt that, it was targeting every vulnerable part of her body, swelling of left (L) Knee, left (L) hip, left (L) arm and kidney. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events swelling of left Knee, left hip, left arm and kidney, labored breathing and exhaustion were unknown at the time of this report.  No follow-up attempts are needed. No further information is expected.
Patient is complaining about a pain that lasted since she had her first TWINRIX vaccine on 5/23/17 until now (10/21/2018) on her right arm, she said she was thinking the pain will fade away after a few days following the vaccination, but her arm is still sore, she reported these symptoms to her Doctor who gave her a prescription of VOLTAREN (prescription dated on 12/19/17), but she says VOLTAREN didn't seem to help her with the pain. (FYI: the patient had received two other vaccines on her left arm the same time (on 5/23/17) : BOOSTRIX and PREVNAR which didn't seem to cause her any pain, and she continued to receive 2 more doses of TWINRIX and the Flu after the incident all injected on her left arm, she has no incidents.
Day 1- fever over 102.5 for 24 hours, extreme stomach and back pain, headache, nausea and dizzy. Days 2-27 and counting. Intense head/neck/sinus pressure, severe headaches and dizziness and lightheaded ness.
A mother reported that her 12 month old daughter received Prevnar, varicella and poliomyelitis vaccines on 10/2/00 and subsequently, developed a fever. On 10/11/00, her fever was 105.2F and the mother reports that she "may have had a febrile seizure because she was not responding appropriately and would just stare ahead at times". The mother treated her with Tylenol and the fever resolved. On 10/13/00, the child developed a rash on her trunk and face. On 10/16/00, she was seen by the physician who dx'd roseola. The roseola resolved on 10/18/00. On 10/23/00, the child developed a cough and fever of 103F. On 10/27/00, the fever resolved and she was seen by the physician who dx'd "a touch of pneumonia" and a left ear infection. She was treated with amoxicillin. As of 10/30/00, the child is improving but has developed "occasional vomiting due to coughing and gagging".
Booster; platelet count drop; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): NVSC2021US300502_OS.  A 26 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 26 years as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose number unknown, Manufacturer unknown), for COVID-19 Immunization. The following information was reported: IMMUNISATION (hospitalization, medically significant), outcome "unknown", described as "Booster"; PLATELET COUNT DECREASED (hospitalization, medically significant), outcome "unknown", described as "platelet count drop". The patient underwent the following laboratory tests and procedures: platelet count: count drop. The Physician told the patient that the event could be from booster shot.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Fever  101, chills, H/A , tiredness, lower back pain, body aches. Felt slightly dizzy at times. Started 1/7/21 @2220. Slept most of 1/8. Medicated with Advil every 4-6 hrs for fever.   Continued until 1/9/21 at 0100. Woke with H/A am 1/9 but no fever. Took last Advil for it.
This spontaneous report as received from a nurse refers to a multiple unspecified patients of unknown age and gender. The patient's medical history, concurrent condition and concomitant medications were not reported. On multiple unspecified date the patients were vaccinated with improperly stored RECOMBIVAX HB (lot N005996 expiry date 07-JUL-2019) or (lot N006321 expiry date 08-NOV-2019) or (lot: M044032, expiry date: 03-JUL-2019) (incorrect product storage) for prophylaxis. No adverse effects reported with any patients. The vaccine was exposed to temperature of 0°C to 1°C for a time frame of 35 minutes. Previous temperature excursion was reported. The call because of a data logger. No PQC involved. No further information provided. This is one of the several reports linked via same reporter link.; Sender's Comments: US-009507513-1708USA008711: US-009507513-1708USA008710: US-009507513-1708USA008409: US-009507513-1708USA008709: US-009507513-1708USA008709: US-009507513-1708USA008709: US-009507513-1708USA008409:
Patient stated she could feel the vaccine going all of the way down her arm. Her mother reported to us the next morning that patient had Swelling at the injection site that went to the top of the shoulder, fatigue, muscle/joint pain, chills and nausea.
Hospital; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Feb-2021 and was forwarded to Moderna on 04-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NOSOCOMIAL INFECTION (Hospital) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NOSOCOMIAL INFECTION (Hospital). At the time of the report, NOSOCOMIAL INFECTION (Hospital) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Bil burning tingling pain of both plantar surface of both feet starting in April. Symptoms worsened after 4th injection on 10/01/2022 of the Pfizer bivalent vaccine.
Initial information received on 05-Nov-2018 regarding an unsolicited non-valid non-serious case received from a consumer. This case involves female patient of an unknown age who experienced sore arm, while she received vaccine FLUBLOK QIV. The patient's past medical history included Pain in extremity, Nausea and Pyrexia. The patient's past vaccination(s) included TDAP with about a year ago at her HCP's office, and the nurse hit her bursa. The patient's past medical treatment(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE lot number not reported. On an unknown date, the patient developed sore arm following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Final diagnosis was sore arm. No lab data reported. It was not reported if the patient received a corrective treatment. The outcome of the event was not reported. Additional information was received from consumer on 05-Nov-2018. Event was updated in field and narrative and case became non-valid to valid. List of documents held by sender - none.
Information has been received from a healthcare professional referring to an unspecified number of patients of unknown age and gender. The nurse reported that the 10 doses of PNEUMOVAX 23 (lot # L003188, expiry date 06-JUL-2016) which were exposed to 18 degree centigrade for 36 hours, had been administered to unspecified patients on unspecified dates since 30-NOV-2015 (dose and route unspecified). She was not aware of any adverse effects. Additional information has been requested.
July / August/ September extreme muscle & joint pain.; July / August/ September extreme muscle & joint pain.; Disturbing my sleep patterns; Unable to move my arms / legs due to inflammation.; Unable to move my arms / legs due to inflammation.; neck upper back muscle pain; neck upper back muscle pain; neck upper back muscle pain; Minimal joint pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date Mar2021 (Lot number: ER8729) at the age of 55 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (product=COVID 19, brand=Pfizer, lot number=EP6955, lot unknown=False, administration date=Mar2021, administration time=11:00 AM, dose number=1, vaccine location=Left arm), administration date: Mar2021, when the patient was 55 years old, for COVID-19 immunisation. The following information was reported: NECK PAIN (non-serious), MYALGIA (non-serious), BACK PAIN (non-serious) all with onset May2021, outcome "not recovered" and all described as "neck upper back muscle pain"; ARTHRALGIA (non-serious) with onset May2021, outcome "not recovered", described as "Minimal joint pain"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "July / August/ September extreme muscle & joint pain."; SLEEP DISORDER (non-serious) with onset Jul2021, outcome "not recovered", described as "Disturbing my sleep patterns"; INFLAMMATION (non-serious), MOVEMENT DISORDER (non-serious) all with onset Jul2021, outcome "not recovered" and all described as "Unable to move my arms / legs due to inflammation.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of neck pain, myalgia, arthralgia, myalgia, arthralgia, sleep disorder, inflammation, movement disorder, back pain.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Case was reported as non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.    No follow-up attempts are possible. No further information is expected.